Most Read Articles
Pearl Toh, Yesterday
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
Rachel Soon, 05 Dec 2018

At the recent Malaysian Community Pharmacy Business Forum (MyCPBF), a discussion forum was held on the subject of “Transcending Primary Healthcare Services: The Future of Specialized Pharmacy Services and Pharmacy Specialization”.

Dr Renly Lim, 01 Aug 2018
Palliative care uses an integrated, multidisciplinary approach to reduce suffering and to improve the quality of life of patients battling with life-threatening illnesses.
Rachel Soon, 01 Mar 2018

Over half of consumers who use herbal supplements still do not inform physicians of their practices in consultation, according to a local study.

Combo therapy extends survival in paediatric ICU patients with S. maltophilia infection

11 Oct 2018

Critically ill children harbouring Stenotrophomonas maltophilia in the intensive care unit (ICU) may benefit from the combination treatment of trimethoprim and sulfamethoxazole, ciprofloxacin, and minocycline, suggests a recent study.

“Meticulous evaluation of central vascular access and prior treatment with carbapenems are indicated, especially for mechanically ventilated and septic children,” the investigators said.

The study identified and reviewed 31 patients and 91 isolates from blood, respiratory secretions and soft tissues. During the study period, an increase in the overall incidence of S. maltophilia infections was observed (p=0.003). There was a 61-percent all-cause crude mortality, while the attributed mortality was approximately 16 percent.

The following risk factors were associated with mortality: longer hospitalization before infection (p=0.002), septic shock (p=0.003), mechanical ventilation (p=0.004), an indwelling central vein catheter (p=0.03) and prior use of steroids (p=0.04) and carbapenems (p=0.004).

Multivariate analysis revealed the association of mortality with mechanical ventilation (p=0.02) and preinfection hospitalization days (p=0.01). Combination treatment of trimethoprim and sulfamethoxazole, ciprofloxacin and/or minocycline significantly extended survival time (p<0.001). The treatment method did not significantly affect the interval between S. maltophilia isolation to resolution of infection (p=0.2).

In this study, a retrospective chart review was conducted involving paediatric patients with isolates of S. maltophilia hospitalized over a 5-year period in two paediatric ICUs.

S. maltophilia is a life-threatening nosocomial pathogen with profound multidrug-resistant attributes. It is associated with high mortality, particularly in immunocompromised patients. Data on therapy for S. maltophilia infections are scarce, especially in children hospitalized in intensive care settings (paediatric ICU),” the investigators said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, Yesterday
First-line therapy with the BTK* inhibitor ibrutinib plus the anti-CD20 immunotherapy rituximab confers significant survival advantage over the current gold-standard regimen of fludarabine, cyclophosphamide, and rituximab (FCR) for young, fit patients with treatment-naïve chronic lymphocytic leukaemia (CLL), according to the E1912 trial, a large cooperative group study supported by the US National Cancer Institute.
Rachel Soon, 05 Dec 2018

At the recent Malaysian Community Pharmacy Business Forum (MyCPBF), a discussion forum was held on the subject of “Transcending Primary Healthcare Services: The Future of Specialized Pharmacy Services and Pharmacy Specialization”.

Dr Renly Lim, 01 Aug 2018
Palliative care uses an integrated, multidisciplinary approach to reduce suffering and to improve the quality of life of patients battling with life-threatening illnesses.
Rachel Soon, 01 Mar 2018

Over half of consumers who use herbal supplements still do not inform physicians of their practices in consultation, according to a local study.